246 Results

People

  1. Old
    Old
  2. Pamer
    Pamer
  3. Houghton
    Houghton
  4. Nikolich-Zugich
    Nikolich-Zugich
  5. Gnjatic
    Gnjatic
  6. Ritter
    Ritter
  7. O'Reilly
    O'Reilly
  8. Dupont
    Dupont
  9. Jungbluth
    Jungbluth
  10. Alpdogan
    Alpdogan

Groups

  1. Department of Medicine (101)
  2. Sloan Kettering Institute Faculty (84)
  3. GSK Faculty (75)
  4. Immunology Program Faculty (60)
  5. Sloan Kettering Institute Postdocs (47)
  6. Hematologic Malignancies, Division of (44)
  7. Department of Pathology and Laboratory Medicine (43)
  8. Center for Hematologic Malignancies (41)
  9. Solid Tumor Oncology Division (40)
  10. Pediatrics, Department of (25)
  1. "cd8 antigen"
Formats
  1. Journal Article (241)
  2. Review (3)
  3. Conference Paper (1)
  4. Editorial (1)
Groups
  1. Department of Medicine (101)
  2. Sloan Kettering Institute Faculty (84)
  3. GSK Faculty (75)
  4. Immunology Program Faculty (60)
  5. Sloan Kettering Institute Postdocs (47)
  6. Hematologic Malignancies, Division of (44)

More Groups

People
  1. Lloyd Old (22)
  2. Eric Pamer (20)
  3. Alan Houghton (17)
  4. Janko Nikolich-Zugich (15)
  5. Sacha Gnjatic (14)
  6. Gerd Ritter (13)

More People

Years
  1. 2025 (12)
  2. 2024 (17)
  3. 2023 (8)
  4. 2022 (7)
  5. 2021 (3)
  6. 2020 (10)

More Years

Publications
  1. Journal of Immunology (25)
  2. Journal of Experimental Medicine (18)
  3. European Journal of Immunology (13)
  4. Blood (12)
  5. Clinical Cancer Research (11)
  6. Proceedings of the National Academy of Sciences of the United States of America (11)

More Publications

Publishers
  1. The American Association of Immunologists, Inc (25)
  2. Rockefeller University Press (20)
  3. Nature Publishing Group (19)
  4. Elsevier Inc. (18)
  5. American Association for Cancer Research (17)
  6. Wiley V C H Verlag Gmbh (13)

More Publishers

Results (246)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
    Journal Article

    Hoefflin, R.; Harlander, S.; Schäfer, S.; Metzger, P.; Kuo, F.; Schönenberger, D.; Adlesic, M.; Peighambari, A.; Seidel, P.; Chen, C. Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma
    Journal Article

    Katsoulakis, E.; Yu, Y.; Apte, A. P.; Leeman, J. E.; Katabi, N.; Morris, L.; Deasy, J. O.; Chan, T. A.; Lee, N. Y.; Riaz, N.; more...
    Oral Oncology (2020)

    Fulltext@MSK | Save
  • Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
    Journal Article

    Jiménez-Sánchez, A.; Cybulska, P.; LaVigne Mager, K.; Koplev, S.; Cast, O.; Couturier, D. L.; Memon, D.; Selenica, P.; Nikolovski, I.; Mazaheri, Y.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Inhibition of JAK2 suppresses myelopoiesis and atherosclerosis in Apoe (−/−) mice
    Journal Article

    Tang, Y.; Liu, W.; Wang, W.; Fidler, T.; Woods, B.; Levine, R. L.; Tall, A. R.; Wang, N.
    Cardiovascular Drugs and Therapy (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Evaluation of the predictive role of tumor immune infiltrate in patients with HER2-positive breast cancer treated with neoadjuvant anti-HER2 therapy without chemotherapy
    Journal Article

    De Angelis, C.; Nagi, C.; Hoyt, C. C.; Liu, L.; Roman, K.; Wang, C.; Zheng, Y.; Veeraraghavan, J.; Sethunath, V.; Nuciforo, P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Pembrolizumab in relapsed and refractory mycosis fungoides and Sézary syndrome: A multicenter phase II study
    Journal Article

    Khodadoust, M. S.; Rook, A. H.; Porcu, P.; Foss, F.; Moskowitz, A. J.; Shustov, A.; Shanbhag, S.; Sokol, L.; Fling, S. P.; Ramchurren, N.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • P2RY8-CRLF2 fusion–positive acute myeloid leukemia with myelodysplasia-related changes: Response to novel therapy
    Journal Article

    Aypar, U.; Taylor, J.; Garcia, J. S.; Momeni-Boroujeni, A.; Gao, Q.; Baik, J.; Londono, D.; Benayed, R.; Sigler, A.; Haddadin, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development
    Journal Article

    Maluski, M.; Ghosh, A.; Herbst, J.; Scholl, V.; Baumann, R.; Huehn, J.; Geffers, R.; Meyer, J.; Maul, H.; Eiz-Vesper, B.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • Globular C1q receptor (gC1qR/p32/HABP1) is overexpressed in malignant pleural mesothelioma and is associated with increased survival in surgical patients treated with chemotherapy
    Journal Article

    Li, X.; Eguchi, T.; Aly, R. G.; Chintala, N. K.; Tan, K. S.; Zauderer, M. G.; Dembitzer, F. R.; Beasley, M. B.; Ghebrehiwet, B.; Adusumilli, P. S.; more...
    Frontiers in Oncology (2019)

    Fulltext@MSK | Save